Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
Q1 2024 vs. Q4 2023
How the institutions holding Oric Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 92 | 112 | +20 |
| Shares | 50.6M | 64.0M | +13.3M (+26.3%) |
| Value | $465.9M | $879.3M | +$413.4M (+88.7%) |
New holders (35)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (15)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Prosight Management, LP | 1,578,263 | $14.5M |
| Janus Henderson Group PLC | 659,054 | $6.07M |
| Point72 Asset Management, L.P. | 521,142 | $4.79M |
| Sphera Funds Management Ltd. | 126,800 | $1.17M |
| D. E. Shaw & Co., Inc. | 98,433 | $905.6K |
| DAFNA Capital Management LLC | 72,797 | $669.7K |
| Susquehanna International Group, LLP | 54,389 | $500.4K |
| Jane Street Group, LLC | 35,274 | $324.5K |
| Gsa Capital Partners LLP | 24,515 | $226.0K |
| Bridgeway Capital Management, LLC | 22,500 | $207.0K |
| Mirae Asset Global Investments Co., Ltd. | 22,043 | $202.8K |
| State Board of Administration of Florida Retirement System | 11,310 | $104.1K |
| AJOVista, LLC | 4,357 | $40.1K |
| Comerica Bank | 1,332 | $12.3K |
| Simplex Trading, LLC | 163 | $1.00K |